Abstract
Graft-versus-host disease (GVHD) is uniformly lethal in recipients of HLA-mismatched marrow. In patients with severe combined immunodeficiency disease, this major obstacle can be overcome by rigorous T-cell depletion before transplantation. In leukaemia patients, however, the benefit of preventing GVHD is offset by graft rejection or graft failure. Very recently, this problem was overcome by supplementing T cell-depleted bone marrow transplants with megadoses of peripheral blood stem cells collected by leukapheresis after mobilization of the donor stem cells with granulocyte colony-stimulating factor (G-CSF). In the present study, we further demonstrate in a mouse model (C57BL/6→C3H/HeJ) that escalation of bone marrow doses by four- to fivefold leads to full donor-type chimerism in sublethally irradiated (6.5 Gy) recipients. Thus, the new source of G-CSF mobilized human haematopoietic stem cells may enable extending the use of mismatched bone marrow transplants to patients with non-malignant diseases for whom supralethal conditioning is not a prerequisite.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reisner, Y. et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow Cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61, 341–348 (1983).
Gale, R.P. & Reisner, Y. Graft rejection and graft-versus-host-disease: Mirror images. Lancet i, 1468–1470 (1986).
Gengozian, N., Carlson, D.E. & Allen, E.M. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure rates. Transplantation 7, 259–273 (1969).
Vriesendorp, H.M. Engraftment of hemopoietic cells. in Bone Marrow Transplantation: Biological Mechanisms and Clinical Practice (ed. Lowenberg, D. W. & van Bekkum, B.) 73–145 (Dekker, New York, 1985).
Lapidot, T., Terenzi, A., Singer, T.S. & Reisner, Y. Size of bone marrow inoculum versus number of donor-type cells used for presensitization: a murine model for bone marrow allograft rejection in leukemia patients. Blood 70, 309a (1987).
Lapidot, T., Terenzi, A., Singer, T.S., Salomon, O. & Reisner, Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 73, 2025–2032 (1989).
Soderling, C.C., Song, C.W., Blazer, B.R. & Vallera, D.A. A correlation between conditioning and engraftment in recipients of MHC mismatched T cell-depleted murine bone marrow transplants. Immunology 135, 941–946 (1985).
Ferrara, J., Lipton, J., Hellman, S., Burakoff, S. & Mauch, P. Engraftment following T cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers. Transplantation 43, 461–467 (1987).
Uharek, L. et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 79, 1612–1621 (1992).
Gianni, A.M. et al. Granulocyte-macrophage colony stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet ii, 580–585 (1989).
Aversa, F. et al. Successful engraftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84, 3948–3955 (1994).
Lapidot, T., Lubin, I., Faktorowich, Y., Erlich, P. & Reisner, Y. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc. natn. Acad. Sci. U.S.A. 87, 4595–4599 (1990).
Martin, P.J. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. exp. Med. 178, 703–712 (1993).
Sykes, M., Sheard, M. & Sachs, D.H. Effects of T Cell depletion in radiation bone marrow chimers. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J. Immun. 141, 2282–2288 (1988).
Navarro, J. & Touraine, J.-L. Promotion of fetal liver engraftment by T-cells in a murine semiallogeneic model without graft-versus-host reaction. Transplantation 47, 871–876 (1989).
Faktorowich, Y., Lapidot, T., Lubin, I. & Reisner, Y. Enhancement of BM allo-grafting from C57BL/6 ‘nude’ mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-C3H/HeJ) and (C3H/HeJ→C57BL/6) chimeras. Bone Marrow Transplant. 12, 15–20 (1993).
Slavin, S., Strober, S., Fuks, Z. & Kaplan, H.S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid iradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J. exp. Med. 146, 34–48 (1977).
Pierce, G. & Watts, L. The role of donor lymphoid cells in the transfer of allograft tolerance. Transplantation 40, 702–707 (1985).
Cobbold, S., Martin, G. & Qin, S. & Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323, 164–166 (1986).
Sharabi, Y. & Sachs, D. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. exp. Med. 169, 493–502 (1989).
Mayumi, H. & Good, R. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance — inducing method using cyclophosphamide. J. exp. Med. 169, 213–238 (1989).
Qin, S., Cobbold, S., Benjamin, R. & Waldmann, H. Induction of classical transplantation tolerance in the adult. J. exp. Med. 169, 779–794 (1989).
Leong, L., Qin, S., Cobbold, S. & Waldmann, H. Classical transplantation tolerance in the adult: The interaction between myeloablation and immunosuppretion. Eur. J. Immun. 22, 2825–2830 (1992).
Pierce, G.E. & Watts, L.M. Do donor cells function as veto cells in the induction and maintenance of tolerance across an MHC disparity in mixed lymphoid radiation chimeras? Transplantation 55, 882–887 (1993).
Pierce, G.E. & Watts, L.M. Thy 1+ donor cells function as veto cells in the maintenance of tolerance across a major histocompatibility complex disparity in mixed-lymphoid radiation chimeras. Transplantn Proc. 25, 331–333 (1993).
Kiyoshi, H., Nakamura, H., Henkart, P. & Gress, R. Clonal deletion of post-thymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J. exp. Med. 175, 863–868 (1992).
Tscherning, T. & Claesson, M. Veto-like down regulation of T helper cell reactivity in vivo by injection of semi-allogeneic spleen cells. Immunology Lett. 29, 223–228 (1991).
Kikuya, S., Inaba, M., Ogata, H., Yasumizu, R. & Inaba, K. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc. natn. Acad. Sci. U.S.A. 85, 4824–4826 (1988).
Strober, S., Palathumpat, V., Schwadron, R. & Hertel-Wulff, B. Cloned natural suppressor cells prevent lethal graft-vs-host disease. J. Immun. 138, 699–703 (1987).
Kaufman, C.L. et al. Phenotypic characterization of a novel bone marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436–2446 (1994).
Ramsdell, F. & Fowlkes, B. Maintenance of in vivo tolerance by persistence of antigen. Science 257, 1130–1134 (1992).
Rocha, B., Tanchot, C. & Von Boehmer, H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. exp. Med. 177, 1517–1521 (1993).
Reisner, Y., Itzicovitch, L., Meshorer, A. & Sharon, N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc. natn. Acad. Sci. U.S.A. 75, 2933–2936 (1978).
Schwartz, E., Lapidot, T., Gozes, D., Singer, T.S. & Reisner, Y. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors. J. Immun. 138, 460–465 (1987).
Ryser, J.E. & MacDonald, H.R. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J. Immun. 122, 1691–1696 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bachar-Lustig, E., Rachamim, N., Li, HW. et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1, 1268–1273 (1995). https://doi.org/10.1038/nm1295-1268
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1295-1268
This article is cited by
-
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Leukemia (2020)
-
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease
Bone Marrow Transplantation (2019)